RNA Sequencing Service
Archived on October 7, 2025. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM CDT
- Posted
- September 17, 2025
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Agriculture
Notice details
- Last updated
- Nov 8, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 1232SA25Q0855
- Notice ID
- cea9a86e04cc4d0b9d33a7a80c408696
Description
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (8)
- Download
Solicitation 1232SA25Q0855-0002.pdf
1.0 MBAdded in Combined Synopsis/Solicitation version 5Posted - Download
Solicitation_1232SA25Q0855_Amd_0002.pdf
88 KBAdded in Combined Synopsis/Solicitation version 5Posted - Download
Attachment 1 Rev 2 - RNA-Seq Performance Work Statement.doc
82 KBAdded in Combined Synopsis/Solicitation version 5Posted - Download
Attachment 1 Rev 1 - RNA-Seq Performance Work Statement.doc
82 KBAdded in Combined Synopsis/Solicitation version 2Posted - Download
1232SA25Q0855 Amendment 0001.pdf
125 KBAdded in Combined Synopsis/Solicitation version 2Posted - Download
Solicitation_1232SA25Q0855.pdf
842 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 1 - RNA-Seq Performance Work Statement.doc
81 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 2 - Wage Determination 2015-4969 Rev 29.pdf
45 KBAdded in Combined Synopsis/Solicitation version 1Posted
Lifecycle
- 1Version 1Combined Synopsis/SolicitationArchived
RNA Sequencing Service
- 2Version 2Combined Synopsis/SolicitationArchived
RNA Sequencing Service
- 5Version 5Combined Synopsis/SolicitationArchivedCurrent
RNA Sequencing Service
- 7Version 7Award NoticeArchived
Type changed from Combined Synopsis/Solicitation to Award Notice
RNA Sequencing Service
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Amendment 0001 to this notice is to push out the anticipated posting of the solicitation to late November 2026. This is a pre-solicitation notice to synopsize the intention of the Defense Health Agency Contracting Activity (DHACA) to issue a Request for Proposal (RFP) for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle covering military medical research and development services. A historical pre-solicitation notice was posted under Notice ID# HT942626RE002, although there were various delays with getting a solicitation out in Fiscal Year 2026. This notice is taking over where Notice ID# HT942626RE002 left off. No further delays are anticipated at this time for this on-ramp. The eventual RFP will be set-aside for small businesses certified under the Small Business Administration 8(a) Program. The Government anticipates making multiple new awards under this on-ramp, and all new awards will align with the existing unrestricted contract vehicle. This notice is not a request for proposals and does not commit the Government to any contractual agreement. The OMNIBUS IV contract vehicle was awarded under full and open competition with a base ordering period of 20 June 2022 through 19 June 2027 and an Option Ordering Period of 20 June 2027 - 19 June 2032. Task orders may be competed under fair opportunity (providing all Contract Holders within a Market Segment the opportunity to submit a proposal) or an exception to fair opportunity (such as set-asides for small businesses or applicable small business socioeconomic categories). The cumulative ceiling of this unrestricted IDIQ contract vehicle is $10 billion. To date, the accumulated awarded task order value (including future unexercised option periods) is over $690 million across 61 task orders. Task Orders have been issued by a growing number of end users including DHACA, the U.S. Army Medical Research Acquisition Activity (now integrated into DHACA), the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences. When excluding the task orders simply providing a minimum guarantee to the existing Contract Holders, 61 task orders have been issued off this contract vehicle with 8 task orders being set aside for the 8(a) Program and 15 task orders being awarded to an 8(a) Participant (based on the most recent representations at the contract level). 42 task orders have been awarded so far to small businesses under this contract vehicle. Of the 61 task orders, 95% were awarded during the Government Fiscal Years 2024 - 2026. Please see attachments for further details. | - | Pre-Solicitation | Open |
Please see attached Sources Sought. Questions & Answers attached. | - | Market Research | 11/12/2026 |
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Amendment 001 - 10/30/26 - Updated the proposal due date from 2/1/27 at 5:00 pm to 1/22/27 at 5:00 pm. Updated the Special Notice Archive date from 15 days after response date to 09/30/27. In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. | - | Special Notice | 01/22/2027 |
The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform the fiscal year 2027 (FY27) Alzheimer’s Research Program (AZRP) research focus areas and associated research funding opportunities. Although FY27 federal funds have not yet been appropriated, the AZRP is collecting this information solely to support strategic program planning. This inquiry does not commit the program to incorporating this feedback into FY27 or any future AZRP funding opportunities. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI should not be construed as a solicitation or an obligation on the part of the AZRP or the Department of War (DoW). BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP AZRP’s vision is to mitigate the impact of Alzheimer's and related dementias associated with TBI, military, and diverse risks. The AZRP’s mission is to fund impactful, solution-oriented research to address critical needs and improve quality of life for Service Members, Veterans, their Families, and the public who are living with Alzheimer's disease and related dementias. Appropriations for the AZRP from FY11-26 totaled $228 million. As of October 2026, FY27 funds for the AZRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process https://cdmrp.health.mil/about/2tierRevProcess) to efficiently manage the AZRP. Additional information about the AZRP can be found here: https://cdmrp.health.mil/azrp/ RESPONSE INSTRUCTIONS: Please provide responses to this RFI by clicking on the following link: https://www.surveymonkey.com/r/FY27-AZRP-RFI | - | Market Research | 12/04/2026 |
The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform the fiscal year 2027 (FY27) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) research focus areas and associated research funding opportunities. Although FY27 federal funds have not yet been appropriated, TBIPRP is collecting this information solely to support strategic program planning. This inquiry does not commit the program to incorporating this feedback into FY27 or any future TBIPHRP funding opportunities. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI should not be construed as a solicitation or an obligation on the part of the TBIPHRP or the Department of War (DoW). BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP TBIPHRP’s vision is to optimize the prevention, assessment, and treatment of psychological health conditions and/or traumatic brain injuries. The TBIPHRP’s mission is to fund research to understand, prevent and treat psychological health conditions and/or traumatic brain injuries that accelerates solutions to improve the health and healthcare of Service Members, their Families, Veterans, and the American public. Appropriations for the TBIPHRP from FY21-24 and FY26 totaled $740.5 million. As of October 2026, FY27 funds for the TBIPHRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process https://cdmrp.health.mil/about/2tierRevProcess) to efficiently manage the TBIPHRP. Additional information about the TBIPHRP can be found here: https://cdmrp.health.mil/tbiphrp/ RESPONSE INSTRUCTIONS: Please provide responses to this RFI by clicking on the following link: https://www.surveymonkey.com/r/FY27-TBIPHRP-RFI | - | Market Research | 12/11/2026 |
Additional Details
Solicitation Number
1232SA25Q0855
Archive Date
Oct 7, 2025